Wetzel Investment Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,500	Closed	-$222K	–	127
2024 Q3	$222K	Buy	3,500 +400	+13%	+$25.3K	0.11%	113
2024 Q2	$254K	Sell	3,100 -500	-14%	-$41K	0.15%	98
2024 Q1	$233K	Buy	3,600 +1,600	+80%	+$103K	0.14%	102
2023 Q4	$37K	Buy	+2,000	New	+$37K	0.02%	285